of platelet aggregation has been demonstrated to improve left ventricular ejection fraction (LVEF) experimentally.' Haemodynamic2 and more recent radio-isotopic3 work has shown that in responsive patients PGE1 increases LVEF by about 40%. We have now assessed the longterm effect of PGE1 in an initially responsive patient.
A 43 year old male patient with a 17-month history of congestive cardiomyopathy exhibited a LVEF of 16% measured by radionuclide ventriculography (RNV). Using the same technique, the response to 10, 20, 40, 60 and 100 ng PGE1 administered intravenously was examined. From the results a dose of 20ng/kg/min was chosen for long-term treatment. PGE1 (kindly provided by SanolSchwarz GmbH, Monheim, FRG) was administered using a portable pump (Pharmacia, Boston, Ma, USA) with a constant infusion rate of 2 ml/h. The reservoir was exchanged three times a week. Clinical assessment, radionuclide ventriculography and platelet function testing were performed monthly for 3 months after starting treatment.
Intravenous PGE1 induced a significant and clinically relevant increase in LVEF (Table I) which was a maximal at PGE1 20ng/kg/min. The improvement in LVEF per-. sisted throughout the entire 3 month follow-up (Table II) . No The early identification of renal impairment in patients with severe liver disease is clearly important. Impairment of hepatocyte function leads to a decreased rate of urea synthesis, and with renal impairment, the rise in plasma urea will be reduced. In contrast, plasma creatinine is largely independent of liver function, and is therefore a better marker for renal impairment in patients with liver disease.3
The above cases, seen over a short period, involved patients with acute, or acute-on-chronic, liver failure. One of the above cases was transferred from a hospital where estimations of plasma creatinine were not carried out acutely, and hence it was not realized that the patient was in established renal failure. In another case the discrepancy between the plasma urea and creatinine, and its implication, was not noted until transfer.
In patients with hepatic failure, an accurate assessment of fluid balance is mandatory, but is often neglected, or carried out inaccurately. 
